Matching Geography

Reports matching your search in:
 
 

Research Assistance

 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!
 

Biotechnology

1594

The biotechnology industry encompasses the spectrum of life science-based research companies developing products and services for a wide variety of industries and applications. The industry holds the promise of transformative technologies from agriculture to materials science to environmental science to medicine. In agriculture, biotech products enhance crop yield, advance the nutritional value and quality of crops and livestock, and improve the efficacy and safety of pesticides.
In material science, biotechnology is adding to advances in polymer science and the coatings industry. In environmental science, biotech has contributed innovative solutions to environmental clean-up and waste management.

The biggest direct impact of biotechnology, and the biggest market for its products, is in medicine and healthcare. The biotechnology industry is, in many ways, becoming the research and development engine of the pharmaceutical industry. The tools and techniques of genetic analysis and manipulation are at the heart of the drug discovery process, and many of the largest biotech firms have been transformed over the past decade into pharmaceutical and biopharmaceutical giants.

The biotechnology category covers the companies, technologies, tools, and applications of the advanced life science sector. Included are reports on research methods and equipment such as liquid chromatography, mass spectroscopy, genetic sequencing, gene expression, etc. There are also reports on the business of biotechnology, mergers & acquisitions, and funding. Insofar as the sector intersects with the pharmaceutical industry, there are also reports on product pipelines, strategies for drug development and manufacturing such as biogenerics, biosimilars and biomanufacturing. Reports cover so-called green- and white-biotech sectors as well.

RSS Feeds

All reports in Biotechnology

< prev 4  5  6  7  8  9  10  11  12  13  next >
South Africa Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and Others
2/29/2012 | published by: GlobalData
... Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and Others” provides key market data on the South Africa Wound Care Management market. The report provides value (USD million), volume (units) and average price (USD) ...  |  more...
$2,500.00
Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - February 2012
2/29/2012 | published by: GlobalData
... and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered ...  |  more...
$1,000.00
Denmark Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and Others
2/29/2012 | published by: GlobalData
... Management, Wound Closure Devices, Pressure Relief Devices and Others” provides key market data on the Denmark Wound Care Management market. The report provides value (USD million), volume (units) and average price (USD) data for each ...  |  more...
$2,500.00
Israel Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and Others
2/29/2012 | published by: GlobalData
... Management, Wound Closure Devices, Pressure Relief Devices and Others” provides key market data on the Israel Wound Care Management market. The report provides value (USD million), volume (units) and average price (USD) data for each ...  |  more...
$2,500.00
Germany Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and Others
2/29/2012 | published by: GlobalData
... Management, Wound Closure Devices, Pressure Relief Devices and Others” provides key market data on the Germany Wound Care Management market. The report provides value (USD million), volume (units) and average price (USD) data for each ...  |  more...
$2,500.00
Pharmaceuticals – Mexico – a snapshot (2011)
2/29/2012 | published by: Mintel - Snapshots
... hospitals, care homes and surgeries. Market value is at prices available to the consumer. Market size for Pharmaceuticals in Mexico is given in MXN with a minimum of five years' historical data. Market Forecast is ...  |  more...
$600.00
Xgeva’s Safety and Efficacy Failings Put Future of Amgen Drug in Question
2/29/2012 | published by: GlobalData
... The report is an essential source of information for the analysis of scope of approval for Xgeva’s extended indication for patients with CRPC who are at high risk of developing bone metastases. However, the unsatisfactory ...  |  more...
$500.00
North America Wound Care Management Market Outlook to 2017 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and Others
2/29/2012 | published by: GlobalData
... Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices and Others” provides key market data on the North America Wound Care Management market – Canada and United States. The report provides value (USD million) data ...  |  more...
$3,500.00
Pharmaceuticals – Sweden – a snapshot (2011)
2/29/2012 | published by: Mintel - Snapshots
... hospitals, care homes and surgeries. Market value is at prices available to the consumer. Market size for Pharmaceuticals in Sweden is given in SEK with a minimum of five years' historical data. Market Forecast is ...  |  more...
$600.00
Cote d'Ivoire Pharmaceuticals and Healthcare Report Q2 2012
2/28/2012 | published by: Business Monitor International
 |  more...
$530.00
Zambia Pharmaceuticals and Healthcare Report Q2 2012
2/28/2012 | published by: Business Monitor International
... alongside a record healthcare budget, will help to revolutionise its provision of healthcare and its focus on human capital. Decentralising healthcare provision should expand access substantially. In the short term, this will not benefit multinational ...  |  more...
$530.00
Advaxis, Inc. (ADXS) - Financial and Strategic SWOT Analysis Review
2/28/2012 | published by: GlobalData
... of cancer disease. It develops proprietary Listeria monocytogenes (Lm) cancer vaccines for the treatment of cervical, breast, prostate, ovarian, lung, and other cancers. Its therapeutic cancer vaccines are developed using its proprietary Lm based system, ...  |  more...
$125.00
Switzerland Pharmaceuticals and Healthcare Report Q1 2012
2/28/2012 | published by: Business Monitor International
... sector. Prescription drug spending accounted for 76% of total drug spending in 2010 and public expenditure on health accounted for 58% of total spending on healthcare. Headline Expenditure Projections Pharmaceuticals: CHF5.88bn (US$5.64bn) in 2010 to ...  |  more...
$1,175.00
Japan Pharmaceuticals and Healthcare Report Q2 2012
2/28/2012 | published by: Business Monitor International
 |  more...
$1,175.00
Amgen Inc. (AMGN) - Financial and Strategic SWOT Analysis Review
2/28/2012 | published by: GlobalData
... and molecular biology. The company markets therapeutic products in the field of supportive cancer care, nephrology and inflammation. It mainly focuses on research and development (R&D) activities to develop novel human therapeutics in the areas ...  |  more...
$125.00
Estonia Pharmaceuticals and Healthcare Report Q2 2012
2/28/2012 | published by: Business Monitor International
... 5.07% in local currency terms through to 2016, with the following five years likely to have similar annual growth rates. Nevertheless, Estonia’s proximity to Western Europe will ensure the market continues to be supplied by ...  |  more...
$530.00
Cougar Biotechnology, Inc. - Strategic SWOT Analysis Review
2/28/2012 | published by: GlobalData
... pipeline product portfolio of the company includes CB7630, which is currently tested in Phase III clinical trial in prostate cancer and Phase I clinical trial in breast cancer; CB3304, which is currently tested in Phase ...  |  more...
$125.00
BTG plc (BGC) - Financial and Strategic SWOT Analysis Review
2/28/2012 | published by: GlobalData
... disorders. It is focused on specialty pharmaceuticals and interventional medicine. BTG also have various products under development through Partnered Programmes. Furthermore, the company receive royalty on sale of its products made by the third-party licensees. ...  |  more...
$125.00
Mozambique Pharmaceuticals and Healthcare Report Q2 2012
2/28/2012 | published by: Business Monitor International
... understaffed by individuals that often lack sufficient training. Current market opportunities are limited to the sale of low-margin, generic drugs, although plans for Mozambique to build its first domestic pharmaceutical production plant – in a ...  |  more...
$1,175.00
Wound Care in China
2/28/2012 | published by: Euromonitor International
... overall improvement in consumer educational levels, Chinese consumers have been more accustomed to using sticking plasters to treat less serious injuries. Euromonitor International's Wound Care in China report offers a comprehensive guide to the size ...  |  more...
$900.00
Wound Care in Chile
2/27/2012 | published by: Euromonitor International
... the health. Euromonitor International's Wound Care in Chile report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you ...  |  more...
$900.00
Pharmaceuticals – Australia – a snapshot (2011)
2/27/2012 | published by: Mintel - Snapshots
... hospitals, care homes and surgeries. Market value is at prices available to the consumer. Market size for Pharmaceuticals in Australia is given in AUD with a minimum of five years' historical data. Market Forecast is ...  |  more...
$600.00
Pharmaceuticals – South Korea – a snapshot (2011)
2/27/2012 | published by: Mintel - Snapshots
... as hospitals, care homes and surgeries. Market value is at prices available to the consumer. Market size for Pharmaceuticals in South Korea is given in KRW with a minimum of five years' historical data. Market ...  |  more...
$600.00
Pharmaceuticals – France – a snapshot (2011)
2/27/2012 | published by: Mintel - Snapshots
... hospitals, care homes and surgeries. Market value is at prices available to the consumer. Market size for Pharmaceuticals in France is given in EUR with a minimum of five years' historical data. Market Forecast is ...  |  more...
$600.00
Wound Care in Canada
2/27/2012 | published by: Euromonitor International
... methodology) Canadians are beginning to take notice and make changes to their lifestyle. National organisations such as ParticipACTION are gaining traction among Canadians, and helping to increase the level of physical activity. This new, higher, ...  |  more...
$900.00
< prev 4  5  6  7  8  9  10  11  12  13  next >